| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/28/2008 | EP1924605A1 Compositions and methods for diagnosing and treating an inflammation |
| 05/28/2008 | EP1924584A1 Use of fused imidazole derivatives to mediate ccr3 related conditions |
| 05/28/2008 | EP1924581A1 Hydroxy substituted 1h-imidazopyridines and methods |
| 05/28/2008 | EP1924286A1 Phrophylactic and/or therapeutic method for treatment of autoimmune disease |
| 05/28/2008 | EP1924274A1 Modulation of cell fates and activities by phthalazinediones |
| 05/28/2008 | EP1924250A2 Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders |
| 05/28/2008 | EP1924159A1 A composition comprising an extract of tiarell polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity |
| 05/28/2008 | EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/28/2008 | EP1605946B1 Thiazoles useful as inhibitors of protein kinases |
| 05/28/2008 | EP1592449B1 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 05/28/2008 | EP1569650B1 Use of levocetirizine for the treatment of persistent allergic rhinitis |
| 05/28/2008 | EP1501507B1 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | EP1471895B1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1399744B1 Epf receptor assays, compounds and therapeutic compositions |
| 05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
| 05/28/2008 | EP1326630B1 Use of glp-2 peptides |
| 05/28/2008 | EP1246925B1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 05/28/2008 | EP1066315B1 Use of inhibitors of mammalian asparaginyl endopeptidase for modulating the immune system |
| 05/28/2008 | EP1017715B1 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 05/28/2008 | EP0968295B1 Vectors having enhanced expression and methods of making and uses thereof |
| 05/28/2008 | CN101186936A Method for producing dry bacterium powder containing gamma-linolenic acid |
| 05/28/2008 | CN101186612A Pyrroline derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/28/2008 | CN101186611A Pyrroline-2-one derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/28/2008 | CN101185736A Orally-administered traditional Chinese medicine for treating acute lupus erythematosus |
| 05/28/2008 | CN101185686A Powder agent medicine for treating eczema |
| 05/28/2008 | CN101185668A Novel preparation for preventing and controlling acquired immuno-deficiency syndrome and protecting liver and detoxication |
| 05/28/2008 | CN101185623A Mycophenolate mofetil dry suspension agent |
| 05/28/2008 | CN100390289C Method for producing influenza hemagglutinin multivalent vaccines |
| 05/28/2008 | CN100390282C Immunocytokines with modulated selectivity |
| 05/28/2008 | CN100390279C Altered polypeptides with increased half-life |
| 05/28/2008 | CN100390274C Method and application of betle extract inducing IFN gamma from human peripheral blood monocyte, and application thereof |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390163C 2-(2,6-dioxopiperidin-3-yl)-isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 05/28/2008 | CN100390158C Novel theterocyclic analogs of diphenylethylene compounds |
| 05/28/2008 | CN100390131C Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 05/28/2008 | CN100389824C 联合疫苗组合物 Combined vaccine composition |
| 05/28/2008 | CN100389821C Stabilized liquid polypeptide-containing pharmaceutical composition |
| 05/28/2008 | CN100389784C Ciliate desert-grass effective parts and allergy-resistant use of effective ingredient |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378525 CCR8 inhibitors |
| 05/27/2008 | US7378444 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/27/2008 | US7378092 Immunogenic compositions for induction of anti-tumor immunity |
| 05/27/2008 | US7378087 Method of enhancing an immune response |
| 05/27/2008 | CA2117181C Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 05/22/2008 | WO2008060540A2 Methods of identifying compositions that modulate the protein tyrosine phosphatase, ptp-bl |
| 05/22/2008 | WO2008060301A1 7-substituted purine derivatives for immunosuppression |
| 05/22/2008 | WO2008060002A1 Polyethylene glycol-g-csf conjugate |
| 05/22/2008 | WO2008059905A1 Raw material for oral product and oral product using the same |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059819A1 Seaweed-derived immunostimulant and antiinflammatory agent |
| 05/22/2008 | WO2008059616A1 Antibody recognizing c-domain of midkine |
| 05/22/2008 | WO2008059491A1 Methods of treating cancer using sirna molecules directed against cd24 |
| 05/22/2008 | WO2008059128A1 Phenylic derivatives and use thereof as drugs |
| 05/22/2008 | WO2008059066A1 New chemokine derivatives of ccl14, synthesis and use as drugs for the treatment of allergic diseases |
| 05/22/2008 | WO2008058728A1 Compositions and methods for immunotherapy |
| 05/22/2008 | WO2008058449A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008058448A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008058396A1 Papaya mosaic virus-based vaccines for influenza |
| 05/22/2008 | WO2008058381A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058380A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058379A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058369A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 05/22/2008 | WO2008039751A3 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 05/22/2008 | WO2008031835A3 Method of treating autoimmune diseases using vegf-pathway inhibitors |
| 05/22/2008 | WO2008011726A8 Staged immune-response modulation in oncolytic therapy |
| 05/22/2008 | WO2008000421A3 Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors |
| 05/22/2008 | US20080119555 Aryl Alkyl Sulfonamides As Therapeutic Agents For The Treatment Of Bone Conditions |
| 05/22/2008 | US20080119532 2-Methylamino-N-{2-(6-{1-methyl-2-(2-methylamino-propionylamino)-3-oxo-3-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-yl]-propoxy}-hexa-2,4-diynyloxy)-1-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-carbonyl]-propyl}-propionamide; mimetics of second mitochondria-derived activator of caspases |
| 05/22/2008 | US20080119526 Ep2 receptor agonists |
| 05/22/2008 | US20080119514 6-(2,4-dinitrophenylazo)-2,5,7,8-tetramethyltridecyl))-1,2,3,4-tetrahydroquinoline; to treat cell proliferative diseases |
| 05/22/2008 | US20080119509 Nontoxic; asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), eosinophilic granuloma, psoriasis |
| 05/22/2008 | US20080119496 7-Substituted Purine Derivatives for Immunosuppression |
| 05/22/2008 | US20080119495 Phosphodiesterase 4 inhibitors |
| 05/22/2008 | US20080119487 Novel non-imidazole compounds |
| 05/22/2008 | US20080119485 Novel Benzofurans and Indols |
| 05/22/2008 | US20080119475 comprises a folate receptor ligand capable of binding to activated macrophages or a vitamin/vitamin-receptor binding analog and immunogen, a cytotoxin, or another compound capable of altering macrophage function |
| 05/22/2008 | US20080119474 5,6-bis(4-methoxyphenyl)-2-ethyl-2H-pyridazin-3-one; interleukin-1 beta antagonist; collagenase inhibitor; analgesic, antiinflammatory, antiarthritic, antiischemic agents; autoimmune disease, rheumatic diseases; osteoporosis |
| 05/22/2008 | US20080119410 comprising administering bactericidal/permeability-increasing protein (BPI proteins) or fragments to a patient suffering from age related macular degeneration (ARMD) |
| 05/22/2008 | US20080119400 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H |
| 05/22/2008 | US20080119390 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 05/22/2008 | US20080118991 Method for isolating and purifying grass pollen allergens |
| 05/22/2008 | US20080118582 herb plant extracts for treating immune disease, with minimal side effects; antidepressants, anticarcinogenic agents; treating HIV |
| 05/22/2008 | US20080118536 A carrier and a grass allergen purified by a combination of hydrophobic interaction chromatography, gel filtration and cation exchange chromatography; antiallergens; improved diagnosis of pollen allergies |
| 05/22/2008 | US20080118530 In a human immunodeficiency virus, E coli, polio virus, a paramyxovirus, a rubella virus, or a coronavirus; increased phenotypic stability of attenuated vaccines; preventing vaccine-associated paralytic poliomyelitis |
| 05/22/2008 | US20080118527 Vaccine comprising hepatitis b viral antigen and hemophilus influenza b protein for use in prevention and treament of viral disease |
| 05/22/2008 | US20080118514 Using toll-like receptor 4 specific immunoglobulin as therapeutic tool in treatment and prevention of inflammatory bowel, atherosclerotic and arthritic disorders |
| 05/22/2008 | US20080118513 Treatment of immune disorders with antibodies to costimulating polypeptide of T cells |
| 05/22/2008 | US20080118511 PD-L2 Molecules: Novel PD-1 Ligands and Uses Therefor |
| 05/22/2008 | US20080118508 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
| 05/22/2008 | US20080118505 Reagents and treatment methods for autoimmune diseases |
| 05/22/2008 | US20080118499 Using concentration of golgi-localized, gamma adaptin ear-containing, ARF-binding (GGA) as diagnostic indicator of beta-site amyloid precursor protein cleaving enzyme (BACE) activity and prognostic tool for detection of cardiovascular, nervous sytem and cell proliferative disorders |
| 05/22/2008 | CA2702370A1 Compositions and methods for immunotherapy |
| 05/22/2008 | CA2669686A1 7-substituted purine derivatives for immunosuppression |